AVTX - Avalo Therapeutics EPS of -$114.00 revenue of $1.92M beats by $0.72M April, 01 2024 01:02 AM Avalo Therapeutics Inc. 2024-04-01 01:02:09 ET More on Avalo Therapeutics Avalo Therapeutics stock more than triples on Anti-IL-1? mAb acquisition Seeking Alpha’s Quant Rating on Avalo Therapeutics Historical earnings data for Avalo Therapeutics Financial information for Avalo Therapeutics For further details see: Avalo Therapeutics EPS of -$114.00, revenue of $1.92M beats by $0.72M